A New Review of Sustained-Release Naltrexone/Bupropion – A Novel Pharmacologic Approach to Obesity and Food Craving
LONDON, October 15, 2015 /PRNewswire/ – US Endocrinology, the peer-reviewed journal, has published a review highlighting the benefits of Sustained-release Naltrexone/Bupropion – A Novel Pharmacologic Approach to Obesity and Food Craving.